AI news impact · China A-shares

Harbin Pharmaceutical Group Co., Ltd. Class A (600664) news impact

On 2026-11-03 Wave Radar's AI rated the news on Harbin Pharmaceutical Group Co., Ltd. Class A as neutral (impact score 0%).

Harbin Pharmaceutical appeared in a list of margin financing favorites, representing routine trading data without specific corporate or fundamental updates.

Direction
Neutral
Impact score
0%
Confidence
30%
Headlines read
1
Date
2026-11-03
Open 600664 news in Wave Radar

AI assessment

Represents routine market margin trading statistics with no corporate fundamental development, likely resulting in a neutral impact.

Sector impact

No noticeable supply chain or peer sector impact.

Headlines the AI read

Rating history

One rating per trading day the stock was covered.

More on Harbin Pharmaceutical Group Co., Ltd. Class A

600664 valuation

How the rating works

After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.